Loading...
OTCM
NUMD
Market cap3mUSD
Jul 11, Last price  
0.04USD
1D
-0.24%
1Q
-53.33%
Jan 2017
-83.20%
IPO
-95.80%
Name

Nu-Med Plus Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
12.90%
Rev. gr., 5y
%
Revenues
0k
Net income
-68k
L-45.55%
-262,744-332,290-1,192,732-1,109,8979,652,4883,577,002-1,188,846-1,054,231-2,023,321-830,061-131,167-125,526-68,345
CFO
-4k
L-93.32%
-830-104,185-140,483-158,257-329,383-180,264-430,510-467,568-567,341-414,799-206,831-38,480-66,389-4,433
Earnings
Aug 19, 2025

Profile

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
IPO date
Aug 02, 2013
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
63
133
193
Unusual Expense (Income)
NOPBT
(63)
(133)
(193)
NOPBT Margin
Operating Taxes
(68)
1,000
Tax Rate
NOPAT
5
(133)
(194)
Net income
(68)
-45.55%
(126)
-4.30%
(131)
-84.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
100
100
Long-term debt
Deferred revenue
Other long-term liabilities
(2,199)
(2,066)
Net debt
(2)
93
27
Cash flow
Cash from operating activities
(4)
(66)
(38)
CAPEX
Cash from investing activities
Cash from financing activities
100
FCF
174
(87)
(318)
Balance
Cash
2
7
73
Long term investments
Excess cash
2
7
73
Stockholders' equity
(9,810)
(9,741)
(9,618)
Invested Capital
9,595
7,496
7,582
ROIC
0.06%
ROCE
29.30%
285.40%
EV
Common stock shares outstanding
83,548
81,674
79,951
Price
0.02
-62.05%
0.04
145.15%
0.02
-52.86%
Market cap
1,282
-61.18%
3,304
150.43%
1,319
-48.63%
EV
1,280
3,397
1,346
EBITDA
(63)
(133)
(182)
EV/EBITDA
Interest
5
5
1,000
Interest/NOPBT